The Food and Drug Administration, Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services today launched the Tri-Agency Task Force for Emergency Diagnostics, which will work to rapidly develop and deploy diagnostic tests to clinical and public laboratories in an emergency. “Timely implementation of [emergency use authorization] diagnostic assays in the U.S. health care system is dependent upon laboratories understanding the instructions for use and applying them to the patient samples received for testing,” said Kate Goodrich, CMS chief medical officer and director of the Center for Clinical Standards and Quality. “As part of this task force, it is our goal to provide clear and consistent guidance to laboratories on the application of [Clinical Laboratory Improvement Amendments] requirements for these emergency assays.”

Related News Articles

Headline
An estimated 9.5% of U.S. residents, or 30.7 million people, lacked health insurance when surveyed in the first six months of 2019, according to preliminary…
Headline
The Food and Drug Administration Friday took steps to encourage and streamline the development of COVID-19 tests whose specimens are collected at home by…
Headline
In a letter to the editor, AHA President and CEO Rick Pollack last week responded to a New York Times article titled “Wealthiest Hospitals Got Billions in…
Headline
The AHA is running ads this week in the Politico Pulse newsletter highlighting the unprecedented ways hospitals and health systems have stepped up to meet the…
Headline
The Department of Health and Human Services today announced a $628 million agreement with Emergent BioSolutions to advance manufacturing capabilities and…
Blog
Rick Pollack President and CEO, American Hospital Association Washington, DC COVID-19 has created the greatest financial crisis in history for hospitals and…